0001181431-13-015379.txt : 20130307
0001181431-13-015379.hdr.sgml : 20130307
20130307165022
ACCESSION NUMBER: 0001181431-13-015379
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130305
FILED AS OF DATE: 20130307
DATE AS OF CHANGE: 20130307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YACHMETZ PHILIP K
CENTRAL INDEX KEY: 0001250318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15313
FILM NUMBER: 13673999
MAIL ADDRESS:
STREET 1: 501 LAFAYETTE AVE
CITY: WYCKOFF
STATE: NJ
ZIP: 07481
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd373175.xml
YACHMETZ FORM 4
X0306
4
2013-03-05
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001250318
YACHMETZ PHILIP K
SAVIENT PHARMACEUTICALS, INC.
400 CROSSING BLVD.
BRIDGEWATER
NJ
08807
0
1
0
0
SVP, General Counsel
Option to Purchase Common Stock
0.94
2013-03-05
4
A
0
110000
0
A
2023-03-05
Common Stock
110000
110000
D
Option to Purchase Common Stock
2.26
2013-03-05
4
A
0
78000
0
A
2022-02-01
Common Stock
78000
78000
D
These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012.
Philip K. Yachmetz
2013-03-07